Trial Profile
A multicenter, open study to evaluate the efficacy of ezetimibe 10 mg added on statin therapy, in reducing LDL [low-density lipoprotein] cholesterol to target levels in patients after acute coronary syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Simvastatin
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Organon
- 28 Apr 2008 New trial record.